UNC Southeastern downgraded as balance sheet continues to weaken

UNC Southeastern, which is now part of the Chapel Hill, N.C.-based UNC Health system, saw its ratings on a series of bonds downgraded to “BB” amid operating losses and sustained weakness in its balance sheet, S&P Global said June 23.

Advertisement

While UNC Southeastern reported an operating loss of $74.8 million in fiscal 2022; such losses have continued into fiscal 2023 with a $15 million loss as of March 31, S&P Global said.

“The speculative-grade rating also incorporates recent and substantial weakening of the balance sheet, particularly DCOH,” the agency noted. UNC Southeastern saw its days of cash on hand more than halved to total 35.7 as of March 31 compared with 75.6 for fiscal 2022.

UNC Southeastern had been placed on CreditWatch with negative implications Feb. 23 when it had a “BBB+” rating. The CreditWatch was removed with the current downgrade.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.